Multidisciplinary management of liver metastases in patients with colorectal cancer:: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM

• E. González-Flores ^[4] ; C. Rubio ^[1] ; J. Urbano ^[5] ; M. Valero Camps ^[6] ; J. J. Ciampi-Dopazo ^[2] ; J. Orcajo Rincón ^[3] ; V. Morillo Macías ^[7] ; M. A. Gomez Braco ^[8] ; G. Suarez-Artacho ; R. Vera ^[9]
  1. [1] Hospital Clinico Universitario de Valencia

     Hospital Clinico Universitario de Valencia

     Valencia, España

     
  2. [2] Complejo Hospitalario de Toledo

     Complejo Hospitalario de Toledo

     Toledo, España

     
  3. [3] Hospital General Universitario Gregorio Marañón

     Hospital General Universitario Gregorio Marañón

     Madrid, España

     
  4. [4] Hospital Virgen de Las Nieves, Granada, Spain
  5. [5] Vascular and Interventional Radiology, Vithas Hospitals Group, Madrid, Spain
  6. [6] Nuclear Medicine, Clínica Rotger (Quiron Salud), Palma de Mallorca, Spain
  7. [7] Radiation Oncology, Hospital Provincial de Castellón, Castellón, Spain
  8. [8] Hepatobiliary and Liver Transplantation Unit, University Hospital Virgen del Rocío, Sevilla, Spain
  9. [9] Hospitalario de Navarra, Calle Irunlarrea, 3, 31008 Pamplona, Navarra, Spain

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 22, Nº. 5, 2020, págs. 647-662
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and the Spanish Society of Nuclear Medicine and Molecular Imaging met to discuss and provide a multidisci-plinary consensus on the management of liver metastases in patients with CRC. The group defined the different scenarios in which the disease can present: fit or unfit patients with resectable liver metastases, patients with potential resectable liver metastases, and patients with unresectable liver metastases. Within each scenario, the different strategies and therapeutic approaches are discussed